H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 1.53 HKD 4.79% Market Closed
Market Cap: 1.5B HKD
Have any thoughts about
Hua Medicine?
Write Note

Operating Margin
Hua Medicine

-247%
Current
-295%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-247%
=
Operating Profit
-269.1m
/
Revenue
108.9m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CN
Hua Medicine
HKEX:2552
1.5B HKD
-247%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
729.3B USD
35%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
DK
Novo Nordisk A/S
CSE:NOVO B
2.6T DKK
44%
US
Johnson & Johnson
NYSE:JNJ
347.8B USD
28%
US
Merck & Co Inc
NYSE:MRK
248.3B USD
34%
CH
Roche Holding AG
SIX:ROG
197.2B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
159B GBP
21%
CH
Novartis AG
SIX:NOVN
169.7B CHF
31%
US
Pfizer Inc
NYSE:PFE
149.4B USD
22%
Country CN
Market Cap 1.5B HKD
Operating Margin
-247%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 729.3B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 2.6T DKK
Operating Margin
44%
Country US
Market Cap 347.8B USD
Operating Margin
28%
Country US
Market Cap 248.3B USD
Operating Margin
34%
Country CH
Market Cap 197.2B CHF
Operating Margin
32%
Country UK
Market Cap 159B GBP
Operating Margin
21%
Country CH
Market Cap 169.7B CHF
Operating Margin
31%
Country US
Market Cap 149.4B USD
Operating Margin
22%
No Stocks Found

Hua Medicine
Glance View

Market Cap
1.5B HKD
Industry
Pharmaceuticals

Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 146 full-time employees. The company went IPO on 2018-09-14. The firm is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The firm mainly operates its business in the domestic and overseas markets.

Intrinsic Value
0.34 HKD
Overvaluation 78%
Intrinsic Value
Price
H

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-247%
=
Operating Profit
-269.1m
/
Revenue
108.9m
What is the Operating Margin of Hua Medicine?

Based on Hua Medicine's most recent financial statements, the company has Operating Margin of -247%.